Dr. Tracy Beth Høeg is stepping down as acting director of the FDA's drug evaluation center amid internal agency conflicts and recent leadership changes. Her tenure was marked by controversy over vaccine policies and regulatory decisions.
Posts tagged as “Sanofi’s Insulins Valyou Savings Program”
The CDC has recommended a new injectable drug, Beyfortus, to protect infants from the respiratory virus RSV. It is a lab-made antibody that helps the immune system fight off the virus and is the first of its kind to be approved by the CDC. It is recommended for babies up to 8 months old born during or entering their first RSV season, and infants between 8 and 19 months who are at increased risk of severe RSV disease. It is expected to be available in the fall and will be given as a single shot.
Sanofi, one of the three major insulin makers in the US, has announced a 78% reduction in the list price of its most widely prescribed insulin, Lantus, and a $35 monthly cap for those with private insurance. Uninsured Americans are eligible for Sanofi’s Insulins Valyou Savings Program. President Joe Biden praised the move, and Eli Lilly and Novo Nordisk have also announced changes to how they price their insulin this month. The Inflation Reduction Act and the actions of the three major insulin makers are a step in the right direction to make insulin more accessible and affordable for people with diabetes.